FDA is reexamining how it defines a dietary substance for novel ingredients
Cara Welch of the FDA's supplement office says a standalone draft guidance could follow, and she welcomes an industry-built list of pre-DSHEA ingredients.
Recap by typeshit. Full story at NutraIngredients-USA.